Cardassian Retroviral Synaptic Encephalitis: Revision history

From Solas Tempus DB

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 November 2023

  • curprev 03:2403:24, 10 November 2023Cyclops talk contribs 5,422 bytes +757 Added section for restrictions on transporting the vaccine
  • curprev 03:1803:18, 10 November 2023Cyclops talk contribsm 4,665 bytes +1 Fixed category
  • curprev 03:1603:16, 10 November 2023Cyclops talk contribs 4,664 bytes +4,664 Created page with "Cardassian Retroviral Synaptic Encephalitis is highly contagious and adaptable, with a vaccination that is 92.7% effective against infection. Treatment is most successful when initiated prior to the onset of neuropathic pain, usually ensuring recovery within 4-5 days. Without treatment, the virus can cause severe cognitive decline and potentially irreversible brain damage, progressing to coma where patients rarely recover due to extensive synaptic damage. Early identific..."